BIOCRYST Trademark

Trademark Overview

On Tuesday, August 14, 2007, a trademark application was filed for BIOCRYST with the United States Patent and Trademark Office. The USPTO has given the BIOCRYST trademark a serial number of 77254503. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 14, 2018. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The BIOCRYST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; pharmaceuticals for the treatment of inflammatory connective tissue disease; pharmaceuticals for the treatment of influenza, hepatitis; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas
biocryst

General Information

Serial Number77254503
Word MarkBIOCRYST
Filing DateTuesday, August 14, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 14, 2018
Registration Number4096431
Registration DateTuesday, February 7, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2008

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; pharmaceuticals for the treatment of inflammatory connective tissue disease; pharmaceuticals for the treatment of influenza, hepatitis; anti-infective pharmaceuticals; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 14, 2018
Primary Code005
First Use Anywhere DateTuesday, August 14, 2007
First Use In Commerce DateTuesday, August 14, 2007

Trademark Owner History

Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 352441879

Trademark Events

Event DateEvent Description
Friday, September 14, 2018CANCELLED SEC. 8 (6-YR)
Thursday, July 12, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 7, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, January 5, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 4, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, January 4, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 14, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 13, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 13, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 13, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 1, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2011NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2011SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 12, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 12, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2011NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2011SU - NON-FINAL ACTION - WRITTEN
Tuesday, April 5, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, April 1, 2011USE AMENDMENT FILED
Friday, April 1, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, September 28, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 27, 2010EXTENSION 5 GRANTED
Wednesday, September 22, 2010EXTENSION 5 FILED
Wednesday, September 22, 2010TEAS EXTENSION RECEIVED
Friday, April 2, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 1, 2010EXTENSION 4 GRANTED
Monday, March 29, 2010EXTENSION 4 FILED
Monday, March 29, 2010TEAS EXTENSION RECEIVED
Thursday, September 24, 2009EXTENSION 3 GRANTED
Monday, September 21, 2009EXTENSION 3 FILED
Monday, September 21, 2009TEAS EXTENSION RECEIVED
Wednesday, April 8, 2009EXTENSION 2 GRANTED
Tuesday, March 24, 2009EXTENSION 2 FILED
Wednesday, April 8, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 24, 2009TEAS EXTENSION RECEIVED
Thursday, September 25, 2008EXTENSION 1 GRANTED
Thursday, September 25, 2008EXTENSION 1 FILED
Thursday, September 25, 2008TEAS EXTENSION RECEIVED
Tuesday, April 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2007NOTICE OF PUBLICATION
Friday, November 30, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 30, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 28, 2007EXAMINER'S AMENDMENT ENTERED
Friday, November 23, 2007ASSIGNED TO LIE
Friday, November 23, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 23, 2007EXAMINERS AMENDMENT E-MAILED
Friday, November 23, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 21, 2007ASSIGNED TO EXAMINER
Friday, August 17, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

biocryst pharmaceuticals treatment cell inflammatory namely cancer infective cancers such lymphomas